Paclip 30mg Injection
Marketer
Alpine Lifescience Private Limited
Salt Composition
Paclitaxel (6mg/ml)
Overview Paclip 30mg Injection
Oncaspar (30mg injectable) is a chemotherapy agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue use only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (hand/facial swelling), alopecia (hair loss), and weight increase are possible. Concomitant medications may be prescribed to mitigate side effects. Report unusual bruising/bleeding, sore throat, oral ulcers, or fever immediately. This medication can decrease blood cell counts (red and white), increasing infection risk. Regular blood work to monitor blood cell levels and liver function is mandatory. Inform your physician of pre-existing cardiac, hepatic, or renal conditions, and all other medications (including antibiotics) prior to commencing treatment. Drug interactions are possible; disclose all medications currently in use. This medication is contraindicated during pregnancy and lactation. Effective contraception for both partners is crucial throughout treatment to prevent conception.
Uses of Paclip 30mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Paclip 30mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Paclip 30mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Paclip 30mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Paclip 30mg Injection works:
Oncaspar 30mg Injection is a cancer treatment agent. Its mechanism of action involves disrupting the microtubules crucial for cancer cell division and proliferation. This inhibits cancerous growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Paclip 30mg Injection poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Administering Paclip 30mg Injection during pregnancy is contraindicated due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Paclip 30mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Paclip 30mg Injection side effects. While there's no inherent prohibition on driving between treatment cycles, the injection's alcohol content suggests caution behind the wheel.
KidneySAFE IF PRESCRIBED
Paclip 30mg Injection poses no known safety concerns for patients with kidney impairment and requires no dosage modification. Nevertheless, consultation with a physician is advised if you have pre-existing kidney conditions.
LiverCAUTION
Patients with hepatic impairment should receive Paclip 30mg Injection cautiously, potentially requiring dose modification. Physician consultation is advised. Paclip 30mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Paclip 30mg Injection :
NA
Facts to Know About Paclip 30mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Taxane-based medications |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Microtubule-targeting drugs: Taxane class |


